190 related articles for article (PubMed ID: 20614148)
1. Identification of hotspot regions of MurB oxidoreductase enzyme using homology modeling, molecular dynamics and molecular docking techniques.
Kumar V; Saravanan P; Arvind A; Mohan CG
J Mol Model; 2011 May; 17(5):939-53. PubMed ID: 20614148
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of UDP-N-acetylglucosamine-enolpyruvate reductase (MurB) from Mycobacterium tuberculosis.
Eniyan K; Dharavath S; Vijayan R; Bajpai U; Gourinath S
Biochim Biophys Acta Proteins Proteom; 2018 Mar; 1866(3):397-406. PubMed ID: 29203374
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of amino acid residues essential for the active site of UDP-N-acetylenolpyruvylglucosamine reductase (MurB) from Staphylococcus aureus.
Nishida S; Kurokawa K; Matsuo M; Sakamoto K; Ueno K; Kita K; Sekimizu K
J Biol Chem; 2006 Jan; 281(3):1714-24. PubMed ID: 16236703
[TBL] [Abstract][Full Text] [Related]
4. The structure of the substrate-free form of MurB, an essential enzyme for the synthesis of bacterial cell walls.
Benson TE; Walsh CT; Hogle JM
Structure; 1996 Jan; 4(1):47-54. PubMed ID: 8805513
[TBL] [Abstract][Full Text] [Related]
5. A structural variation for MurB: X-ray crystal structure of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (MurB).
Benson TE; Harris MS; Choi GH; Cialdella JI; Herberg JT; Martin JP; Baldwin ET
Biochemistry; 2001 Feb; 40(8):2340-50. PubMed ID: 11327854
[TBL] [Abstract][Full Text] [Related]
6. Structure-based virtual screening, free energy of binding and molecular dynamics simulations to propose novel inhibitors of Mtb-MurB oxidoreductase enzyme.
Nirwan S; Chahal V; Kakkar R
J Biomol Struct Dyn; 2021 Feb; 39(2):656-671. PubMed ID: 31906796
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
Saxena S; Abdullah M; Sriram D; Guruprasad L
J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
[TBL] [Abstract][Full Text] [Related]
8. In silico identification, synthesis and biological evaluation of novel tetrazole inhibitors of MurB.
Hrast M; Jukič M; Patin D; Tod J; Dowson CG; Roper DI; Barreteau H; Gobec S
Chem Biol Drug Des; 2018 Jun; 91(6):1101-1112. PubMed ID: 29363274
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive structural and functional characterization of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (Mtb-MurA) and prediction of its accurate binding affinities with inhibitors.
Babajan B; Chaitanya M; Rajsekhar C; Gowsia D; Madhusudhana P; Naveen M; Chitta SK; Anuradha CM
Interdiscip Sci; 2011 Sep; 3(3):204-16. PubMed ID: 21956743
[TBL] [Abstract][Full Text] [Related]
10. MurB as a target in an alternative approach to tackle the Vibrio cholerae resistance using molecular docking and simulation study.
Ragunathan A; Malathi K; Anbarasu A
J Cell Biochem; 2018 Feb; 119(2):1726-1732. PubMed ID: 28786497
[TBL] [Abstract][Full Text] [Related]
11. Substrate Channel Flexibility in Pseudomonas aeruginosa MurB Accommodates Two Distinct Substrates.
Chen MW; Lohkamp B; Schnell R; Lescar J; Schneider G
PLoS One; 2013; 8(6):e66936. PubMed ID: 23805286
[TBL] [Abstract][Full Text] [Related]
12. Characterization of NADP+ binding to perdeuterated MurB: backbone atom NMR assignments and chemical-shift changes.
Constantine KL; Mueller L; Goldfarb V; Wittekind M; Metzler WJ; Yanchunas J; Robertson JG; Malley MF; Friedrichs MS; Farmer BT
J Mol Biol; 1997 Apr; 267(5):1223-46. PubMed ID: 9150408
[TBL] [Abstract][Full Text] [Related]
13. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in-vitro and in-silico study of novel thiazoles as potent antibacterial agents and MurB inhibitors.
Sanad SMH; Ahmed AAM; Mekky AEM
Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900309. PubMed ID: 31967349
[TBL] [Abstract][Full Text] [Related]
15. Exploring the molecular basis for selective binding of Mycobacterium tuberculosis Asp kinase toward its natural substrates and feedback inhibitors: a docking and molecular dynamics study.
Chaitanya M; Babajan B; Anuradha CM; Naveen M; Rajasekhar C; Madhusudana P; Kumar CS
J Mol Model; 2010 Aug; 16(8):1357-67. PubMed ID: 20140471
[TBL] [Abstract][Full Text] [Related]
16. Identification of amino acids involved in catalytic process of M. tuberculosis GlmU acetyltransferase.
Zhou Y; Yu W; Zheng Q; Xin Y; Ma Y
Glycoconj J; 2012 Aug; 29(5-6):297-303. PubMed ID: 22669463
[TBL] [Abstract][Full Text] [Related]
17. (E)-enolbutyryl-UDP-N-acetylglucosamine as a mechanistic probe of UDP-N-acetylenolpyruvylglucosamine reductase (MurB).
Lees WJ; Benson TE; Hogle JM; Walsh CT
Biochemistry; 1996 Feb; 35(5):1342-51. PubMed ID: 8634262
[TBL] [Abstract][Full Text] [Related]
18. X-ray crystal structures of the S229A mutant and wild-type MurB in the presence of the substrate enolpyruvyl-UDP-N-acetylglucosamine at 1.8-A resolution.
Benson TE; Walsh CT; Hogle JM
Biochemistry; 1997 Jan; 36(4):806-11. PubMed ID: 9020778
[TBL] [Abstract][Full Text] [Related]
19. Isolation and mutation site determination of the temperature-sensitive murB mutants of Staphylococcus aureus.
Matsuo M; Kurokawa K; Nishida S; Li Y; Takimura H; Kaito C; Fukuhara N; Maki H; Miura K; Murakami K; Sekimizu K
FEMS Microbiol Lett; 2003 May; 222(1):107-13. PubMed ID: 12757953
[TBL] [Abstract][Full Text] [Related]
20. An enzyme-substrate complex involved in bacterial cell wall biosynthesis.
Benson TE; Filman DJ; Walsh CT; Hogle JM
Nat Struct Biol; 1995 Aug; 2(8):644-53. PubMed ID: 7552726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
